Antifungal susceptibility profile of clinical Trichosporon asahii and Trichosporon asteroides isolates identified by molecular methods
Al-Mahmeed, M.; Khan, Z.U.; Ahmad, S.; Chehadeh, W.
Journal of ChemoTherapy 21(3): 360-362
2009
ISSN/ISBN: 1973-9478
PMID: 19567360
DOI: 10.1179/joc.2009.21.3.360
Accession: 051581804
PDF emailed within 0-6 h: $19.90
Related References
Mariné, Mçal.; Bom, V.Leite.Pedro.; de Castro, P.Alves.; Winkelstroter, L.Kretli.; Ramalho, L.Naira.; Brown, N.Andrew.; Goldman, G.Henrique. 2015: The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin Virulence 6(5): 476-486Arikan, S.; Hasçelik, Gülşen. 2002: Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates Diagnostic Microbiology and Infectious Disease 43(2): 107-111
Pontes, Z.B.V. da S.; Lima, E. de O.; Cechinel Filho, V. 2007: Profile of susceptibility in vitro of Trichosporon asahii and Trichosporon inkin strains against cyclic imides Revista Brasileira de Ciencias Farmaceuticas 43(2): 273-279
Chagas-Neto, T.C.; Chaves, G.M.; Melo, A.S.A.; Colombo, A.L. 2009: Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing Journal of Clinical Microbiology 47(4): 1074-1081
Montoya, A.M.; Elizondo-Zertuche, M.; Treviño-Rangel, R.d.J.; Becerril-García, M.; González, G.M. 2018: Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients Revista Iberoamericana de Micologia 35(1): 22-26
Davies, G.E.; Thornton, C.R. 2014: Differentiation of the emerging human pathogens Trichosporon asahii and Trichosporon asteroides from other pathogenic yeasts and moulds by using species-specific monoclonal antibodies Plos one 9(1): E84789
Cordeiro, R.d.A.; Aguiar, A.L.R.; da Silva, B.N.; Pereira, L.ív.M.G.; Portela, F.V.M.; de Camargo, Z.P.; de Lima-Neto, R.G.ça.; Castelo-Branco, D.éb.d.S.C.M.; Rocha, M.F.áb.G.; Sidrim, J.é J.úl.C. 2021: Trichosporon asahii and Trichosporon inkin Biofilms Produce Antifungal-Tolerant Persister Cells Frontiers in Cellular and Infection Microbiology 11: 645812
Cordeiro, R.d.A.; Pereira, L.ív.M.G.; de Sousa, J.é K.; Serpa, R.; Andrade, A.R.C.; Portela, F.V.M.; Evangelista, A.ôn.J.é d.J.; Sales, J.A.; Aguiar, A.L.R.; Mendes, P.íc.B.L.; Brilhante, R.S.âm.N.; Sidrim, J.é J.úl.d.C.; Castelo-Branco, D.éb.d.S.C.M.; Rocha, M.F.G. 2019: Farnesol inhibits planktonic cells and antifungal-tolerant biofilms of Trichosporon asahii and Trichosporon inkin Medical Mycology 57(8): 1038-1045
Cong, L.; Liao, Y.; Yang, S.; Yang, R. 2016: In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates Plos one 11(12): E0167903
Rastogi, V.; Honnavar, P.; Rudramurthy, S.M.; Pamidi, U.; Ghosh, A.; Chakrabarti, A. 2016: Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India Mycoses 59(8): 528-534
Liao, Y.; Yang, S.; Cong, L.; Lu, X.; Ao, J.; Yang, R. 2014: In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates Antimicrobial Agents and ChemoTherapy 58(12): 7615-7616
Nobrega de Almeida, J.ão.; Jimenez-Ortigosa, C.; Francisco, E.C.; Colombo, A.L.; Perlin, D.S. 2022: ERG11 Analysis among Clinical Isolates of Trichosporon asahii with Different Azole Susceptibility Profiles Antimicrobial Agents and ChemoTherapy 66(12): E0110122
Francisco, E.C.; de Almeida Junior, J.ão.N.; Queiroz-Telles, F.áv.; Aquino, V.ér.R.; Mendes, A.V.A.; de Oliveira Silva, M.; Castro, P.d.T.O.E.; Guimarães, T.; Ponzio, V.; Hahn, R.C.; Chaves, G.M.; Colombo, A.L. 2021: Correlation of Trichosporon asahii Genotypes with Anatomical Sites and Antifungal Susceptibility Profiles: Data Analyses from 284 Isolates Collected in the Last 22 Years across 24 Medical Centers Antimicrobial Agents and ChemoTherapy 65(3)
Lemes, R.M.L.; Lyon, J.P.; Moreira, L.M.; de Resende, M.A. 2010: Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSi and etest methodologies Brazilian Journal of Microbiology: 41(2): 310-315
Alastruey-Izquierdo, A.; Cuenca-Estrella, M.; Monzón, A.; Mellado, E.; Rodríguez-Tudela, J.Luís. 2008: Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods Journal of Antimicrobial ChemoTherapy 61(4): 805-809
Menezes, E.A.; Marinho, J.é A.éc.d.S.; Angelo, M.R.ê F.; Cunha, M.d.C.ção.d.S.O.; Cunha, F.A.ân.; Vasconcelos Júnior, A.ôn.A.d. 2012: Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceará, Brazil Revista do Instituto de Medicina Tropical de Sao Paulo 54(1): 1-3
Pulpillo Ruiz, A.; Sanchez Conejomir, J.; Del Canto Gonzalez, S.; Navarrete Ortega, M.; Perez de Soto, I. 2001: Infección sistémica por Trichosporon asahii - Disseminated infection due to Trichosporon asahii Actas Dermo-Sifiliograficas (Ed. Impresa) 92(7-8): 354-357
Xia, Z.; Yang, R.; Wang, W.; Cong, L. 2012: Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients Mycopathologia 173(2-3): 127-133
Mekha, N.; Sugita, T.; Ikeda, R.; Nishikawa, A.; Autthateinchai, R.; Poonwan, N.; Sawanpanyalert, P. 2010: Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients Mycopathologia 169(1): 67-70
Almeida, A.A.új.d.; Crispim, B.d.A.; Grisolia, A.éi.B.; Svidzinski, T.I.E.; Ortolani, L.G.ça.; Oliveira, K.M.P.d. 2016: Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients Revista Argentina de Microbiologia 48(1): 62-66